Oncoinvent ASA (OSL:ONCIN)
Norway · Delayed Price · Currency is NOK 84.20
+1.00 (1.20%)
Aug 24, 2026, 4:25 PM CET
Oncoinvent ASA Market Cap
Oncoinvent ASA has a market cap or net worth of 377.08 million as of August 24, 2026.
Market Cap
377.08M
Enterprise Value
203.03M
Revenue
28.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
84.20
ChartMarket Cap Chart
Since October 30, 2025, Oncoinvent ASA's market cap has increased from 186.40M to 377.08M, an increase of 102.29%. That is a compound annual growth rate of 137.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 377.08M | 71.49% |
| Dec 30, 2025 | 219.89M | 17.96% |
| Oct 30, 2025 | 186.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Thor Medical ASA | 2.41B |
| Circio Holding ASA | 2.19B |
| Nykode Therapeutics AS | 1.47B |
| ArcticZymes Technologies ASA | 1.06B |
| Zelluna ASA | 655.93M |
| Lytix Biopharma ASA | 576.75M |
| SoftOx Solutions AS | 226.36M |
| Aqua Bio Technology ASA | 77.43M |